Asare O, Shim L, Lee C, Delgado J, Quailes N, Zavala K
Cell Death Discov. 2025; 11(1):80.
PMID: 40021617
PMC: 11871011.
DOI: 10.1038/s41420-025-02353-8.
Parveen S, Ikhlas S, Faruqui T, Hasan A, Khatoon A, Saeed M
ACS Omega. 2025; 10(1):871-884.
PMID: 39829452
PMC: 11740127.
DOI: 10.1021/acsomega.4c07924.
Bertova A, Kontar S, Ksinanova M, Vergara A, Sulova Z, Breier A
Int J Mol Sci. 2025; 25(24.
PMID: 39769273
PMC: 11677715.
DOI: 10.3390/ijms252413511.
Chavda J, Siwach A, Sabharwal S, Janaagal A, Bhatia D, Gupta I
ACS Med Chem Lett. 2024; 15(12):2115-2120.
PMID: 39691523
PMC: 11647722.
DOI: 10.1021/acsmedchemlett.4c00275.
Brokowska J, Herman-Antosiewicz A, Hac A
Eur J Nutr. 2024; 64(1):46.
PMID: 39680190
PMC: 11649724.
DOI: 10.1007/s00394-024-03539-z.
Lysosomal gene ATP6AP1 promotes doxorubicin resistance via up-regulating autophagic flux in breast cancer.
Fei Y, Yan X, Liang M, Zhou S, Xu D, Li L
Cancer Cell Int. 2024; 24(1):394.
PMID: 39627767
PMC: 11616228.
DOI: 10.1186/s12935-024-03579-9.
MiR-155-5p regulates autophagy and apoptosis of glioma cells through RICTOR.
Guo Z, Tian J, Wang Y, Jiang L, Chen Y, Dai H
Transl Cancer Res. 2024; 13(10):5509-5521.
PMID: 39525027
PMC: 11543026.
DOI: 10.21037/tcr-24-543.
T1/T2 Proportional Magnetic Resonance Nanoprobe Monitoring Tumor Autophagy during Chemotherapy.
Cui J, Zhang T, Wang F, Feng L, Deng G, Wu T
Nanomaterials (Basel). 2024; 14(20).
PMID: 39453009
PMC: 11510095.
DOI: 10.3390/nano14201673.
Mechanism of Drug Resistance to First-Line Chemotherapeutics Mediated by TXNDC17 in Neuroblastomas.
Zeng C, Li Z, Wei Z, Chen T, Wang J, Huang J
Cancer Rep (Hoboken). 2024; 7(10):e70033.
PMID: 39411839
PMC: 11480999.
DOI: 10.1002/cnr2.70033.
Role of circRNAs in regulating cell death in cancer: a comprehensive review.
Saadh M, Ehymayed H, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B
Cell Biochem Biophys. 2024; 83(1):109-133.
PMID: 39243349
DOI: 10.1007/s12013-024-01492-6.
TP53AIP1 induce autophagy via the AKT/mTOR signaling pathway in the breast cancer cells.
Liu S, Xu T, Chen X, Tang L, Li L, Zhang L
Cancer Biol Ther. 2024; 25(1):2398297.
PMID: 39223776
PMC: 11376407.
DOI: 10.1080/15384047.2024.2398297.
Navigating the labyrinth of long non-coding RNAs in colorectal cancer: From chemoresistance to autophagy.
Yu J, Sun C, Xu H, Jiang Y, Jiang X, Ni S
World J Gastrointest Oncol. 2024; 16(8):3376-3381.
PMID: 39171173
PMC: 11334040.
DOI: 10.4251/wjgo.v16.i8.3376.
SVIP reduces IGFBP-2 expression and inhibits glioblastoma progression via stabilizing PTEN.
Wang Z, Qiao X, Chen Y, Peng N, Niu C, Wang Y
Cell Death Discov. 2024; 10(1):362.
PMID: 39138166
PMC: 11322382.
DOI: 10.1038/s41420-024-02130-z.
Hotspots and frontiers of autophagy and chemotherapy in lung cancer: a bibliometric and visualization analysis from 2003 to 2023.
Lv M, Feng Y, Zeng S, Zhang Y, Shen W, Guan W
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1583-1595.
PMID: 39120721
DOI: 10.1007/s00210-024-03354-7.
The 3,3'-dimethoxy-4,4'-dihydroxy-stilbene Triazole (STT) Inhibits Liver Cancer Cell Growth by Targeting Akt/mTOR Pathway.
Sun M, Bai J, Wang H, Zhou L, Li S
Dokl Biochem Biophys. 2024; 517(1):277-284.
PMID: 39002015
DOI: 10.1134/S1607672923600537.
An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives.
Zhang H, Li Y, Liu Y
Front Pharmacol. 2024; 15:1374264.
PMID: 38962311
PMC: 11220241.
DOI: 10.3389/fphar.2024.1374264.
Nanotherapeutics targeting autophagy regulation for improved cancer therapy.
Liu Y, Wang Y, Zhang J, Peng Q, Wang X, Xiao X
Acta Pharm Sin B. 2024; 14(6):2447-2474.
PMID: 38828133
PMC: 11143539.
DOI: 10.1016/j.apsb.2024.03.019.
β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy.
Zhang R, Zheng Y, Zhu Q, Gu X, Xiang B, Gu X
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794196
PMC: 11124058.
DOI: 10.3390/ph17050626.
Exogenous Metabolic Modulators Improve Response to Carboplatin in Triple-Negative Breast Cancer.
Ho A, Kiesel V, Gates C, Brosnan B, Connelly S, Glenny E
Cells. 2024; 13(10).
PMID: 38786030
PMC: 11119195.
DOI: 10.3390/cells13100806.
Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
Yun H, Kwon H, Lee J, Park K
Int J Mol Sci. 2024; 25(7).
PMID: 38612399
PMC: 11012096.
DOI: 10.3390/ijms25073582.